Form 4: Lemaitre Vascular Director John A. Roush Reports Changes in Beneficial Ownership

Director John A. Roush reports acquisition of dividend equivalent rights related to restricted stock units and performance share units.

Summary

• On March 28, 2024, John A. Roush, a director of Lemaitre Vascular Inc. (LMAT), reported the acquisition of dividend equivalent rights.
• These rights are associated with previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
• The dividend equivalent rights vest proportionately with the underlying awards and are economically equivalent to shares of LMAT common stock.
• The acquired dividend equivalent rights are linked to RSU awards granted on December 11, 2021, December 12, 2022, and December 8, 2023, as well as a PSU award granted on December 12, 2022.
• The total dividend equivalent rights acquired are 0.476, 0.9644, 0.9644, and 1.2345, corresponding to the respective grant dates.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, indicating standard insider activity related to equity compensation. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Positives

• The acquisition of dividend equivalent rights suggests continued alignment of the director's interests with those of the shareholders.
• The vesting schedule tied to the underlying awards incentivizes long-term performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of dividend equivalent rights has a minimal direct impact on stakeholders.
• It reflects the ongoing compensation structure for company directors.

Key Dates